These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36109434)

  • 1. Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials.
    Kuribayashi K; Cao C
    Ther Innov Regul Sci; 2023 Mar; 57(2):220-226. PubMed ID: 36109434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of estimand framework to the design and analysis of multi-regional clinical trials.
    Niu C; Liang L; Fu R; Zhong W; Wang WWB
    J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan.
    Aoi Y; Kato Y; Asano K; Otsubo Y; Uyama Y
    Ther Innov Regul Sci; 2023 Nov; 57(6):1298-1303. PubMed ID: 37587270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.
    Ushijima S; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2021 Jul; 35(4):253-260. PubMed ID: 34291425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian design of multi-regional clinical trials with time-to-event endpoints.
    Bean NW; Ibrahim JG; Psioda MA
    Biometrics; 2023 Dec; 79(4):3586-3598. PubMed ID: 36594642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
    Sai K; Nakatani E; Iwama Y; Hiraoka S; Tohkin M; Uyama Y; Saito Y
    Ther Innov Regul Sci; 2021 May; 55(3):523-538. PubMed ID: 33393013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
    Asano K; Aoi Y; Kamada S; Uyama Y; Tohkin M
    Clin Pharmacol Ther; 2021 Jun; 109(6):1555-1563. PubMed ID: 33245786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints.
    Huang WS; Hung HN; Hamasaki T; Hsiao CF
    PLoS One; 2017; 12(6):e0180405. PubMed ID: 28665972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.
    Nielsen HK; DeChiaro S; Goldman B
    Front Med (Lausanne); 2021; 8():662775. PubMed ID: 34136501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing consistency across all regions in a multi-regional clinical trial.
    Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF
    Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian multiregional clinical trials using model averaging.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2023 Apr; 24(2):262-276. PubMed ID: 34296263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials.
    Chen J; Zheng H; Quan H; Li G; Gallo P; Ouyang SP; Binkowitz B; Ting N; Tanaka Y; Luo X; Ibia E;
    Clin Trials; 2013; 10(6):842-51. PubMed ID: 24013404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances.
    Wu YJ; Cheng YC; Chiang C; Cheng LH; Liu CT; Hsiao CF
    Stat Med; 2022 Jan; 41(1):87-107. PubMed ID: 34705292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials.
    Quan H; Mao X; Tanaka Y; Binkowitz B; Li G; Chen J; Zhang J; Zhao PL; Ouyang SP; Chang M
    Contemp Clin Trials; 2017 Jul; 58():13-22. PubMed ID: 28455233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional consistency assessment in multiregional clinical trials.
    Li G; Quan H; Wang Y
    J Biopharm Stat; 2024 Apr; ():1-13. PubMed ID: 38557292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-regional clinical trial design and consistency assessment of treatment effects.
    Quan H; Mao X; Chen J; Shih WJ; Ouyang SP; Zhang J; Zhao PL; Binkowitz B
    Stat Med; 2014 Jun; 33(13):2191-205. PubMed ID: 24515845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size allocation in multiregional equivalence studies.
    Liao JJZ; Yu Z; Li Y
    Pharm Stat; 2018 Sep; 17(5):570-577. PubMed ID: 29911346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian approach based on discounting factor for consistency assessment in multi-regional clinical trial.
    Tong L; Li C; Xia J; Wang L
    J Biopharm Stat; 2024 Mar; ():1-17. PubMed ID: 38506674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.